TriReme Medical, Inc. Glider(TM) PTCA Balloon Catheter
DevicePercutaneous Coronary Interventions performed with the Glider PTCA Balloon Catheter
NCT Number: NCT01184352
The objective of this Registry is to demonstrate the utility of the Glider PTCA Balloon Catheter for crossing during the treatment of coronary artery disease.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Vivantes Klinikum Zum Friedrichshain, Berlin, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Percutaneous Coronary Interventions performed with the Glider PTCA Balloon Catheter
Time frame: average of 1 hour
Percentage of lesions successfully crossed among those attempted with the Glider PTCA Balloon Catheter as assesed during procedure.
Time frame: average of 2 days
Percentage of patients treated with at least one Glider PTCA Balloon Catheter having <50% residual diameter stenosis, or TIMI 3 flow if at a bifurcation side branch, without the development of in-hospital MACE (Major Adverse Cardiac Event).
TriReme Medical, LLC
Industry
Registry for PCI With the TriReme Medical, Inc. Glider(TM) PTCA Balloon Catheter
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT02579655
Brain Diseases, Cardiovascular Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT04580017
Angina Pectoris, Angina, Unstable
Hammam Sousse, Sousse Governorate, Tunisia
View Trial DetailsNCT00248352
Arterial Occlusive Diseases, Arteriosclerosis
Ottawa, Ontario, Canada
View Trial Details